• Molbio Diagnostics

  Participated · Equity · Aug 2026

  Incorporated in 2000 and based in Goa, Molbio Diagnostics develops and manufactures the Truenat point-of-care PCR platform and test kits for molecular diagnosis across more than 30 diseases including tuberculosis, COVID, HIV, HPV and hepatitis B and C. Its battery-operated Truenat platform is patented in over 100 countries and is designed for deployment in resource-limited settings to enable decentralized diagnosis within an hour. The company operates six manufacturing facilities in India (two in Goa, two in Bengaluru, and one each in Visakhapatnam and Pune) with an installed capacity of 5,400 devices per annum and 3.9 crore Truenat test kits annually as of March 31, 2026. Financially, Molbio reported revenue from operations of ₹1,445 crore and profit of ₹164 crore for fiscal 2026. The company intends to expand R&D and manufacturing capacity using proceeds from its IPO, including funds earmarked for a Centre of Excellence, additional infrastructure and new plant and machinery. Its shares are proposed to be listed on the BSE and NSE on August 17, 2026.

• KreditBee

  Participated · Series E · Apr 2026

  KreditBee was reported by Moneycontrol to have raised $280 million in a funding round that propelled it into unicorn status. The article identifies the company as a fintech but does not provide additional operational or product details. No revenue, user metrics, or other performance data were mentioned in the coverage. The report did not include the company's founding year or headquarters location. Future plans or stated use of the new capital were not detailed in the article.

• Canara HSBC Life

  Participated · Equity · Oct 2025

  Founded in 2007, Canara HSBC Life Insurance Company Ltd operates as a private, bank-promoted life insurer in India, offering term, savings, and other life insurance products primarily through the branch networks of its promoter banks. The company is a joint venture in which Canara Bank holds 51 %, HSBC Insurance (Asia-Pacific) Holdings owns 26 %, and Punjab National Bank is a minority shareholder. Over the years, the insurer has established itself as a significant player among private life insurance providers that leverage bancassurance distribution. To unlock shareholder liquidity, the firm is pursuing a public listing via a ₹2,516 crore initial public offering structured entirely as an offer for sale. Because the IPO is an OFS, the company itself will not receive primary capital; instead, proceeds will flow to the selling shareholders. Ahead of the IPO, the company allotted shares to anchor investors to bolster demand and provide pricing stability. Post-listing, Canara HSBC Life will gain enhanced public visibility and a broadened shareholder base, which management hopes will support future growth initiatives in India’s expanding life insurance market.

• WeWork India

  Participated · Equity · Oct 2025

  Founded in May 2016 and headquartered in Bengaluru, WeWork India provides a range of flexible workspace solutions under the global WeWork brand. Its portfolio spans 59 operational centres with 94,440 desks across 6.48 million square feet of leasable area as of September 30 2024. Management states the business is now self-sustaining, having invested heavily in infrastructure over the past eight years and recently using internal funds to pay down debt. Current cash generation is sufficient to fund ongoing operations and further expansion, so the company is not seeking primary capital in its IPO. Instead, the listing is intended to provide liquidity and position the company for future growth opportunities using existing resources. WeWork India benefits from affiliation with WeWork Global, which operates in 35 countries and roughly 600 locations worldwide, augmenting brand recognition and enterprise customer acquisition.

• Lenskart

  Participated · Equity · Oct 2025

  Lenskart operates as a multi-category eyewear retailer, offering prescription eyeglasses, sunglasses and contact lenses under its own brand. The company caters to customers looking for affordable and stylish vision-care products. In preparation for its public listing, Lenskart has set an IPO price band of ₹382–₹402 per share. Ahead of the IPO, it has already secured significant capital through an anchor allocation, reflecting institutional confidence in the business. While detailed revenue or user metrics were not disclosed, the sizable anchor book suggests robust market interest and expectations for continued growth. The upcoming IPO will provide additional capital for expansion and operational initiatives once the public issue is completed.

No current team members are available.